(NASDAQ: SRTA) Strata Critical Medical's forecast annual revenue growth rate of 12.27% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.33%.
Strata Critical Medical's revenue in 2026 is $255,975,000.On average, 6 Wall Street analysts forecast SRTA's revenue for 2026 to be $26,241,023,996, with the lowest SRTA revenue forecast at $25,064,415,476, and the highest SRTA revenue forecast at $27,170,810,127. On average, 5 Wall Street analysts forecast SRTA's revenue for 2027 to be $29,425,829,012, with the lowest SRTA revenue forecast at $27,916,585,301, and the highest SRTA revenue forecast at $30,932,418,718.
In 2029, SRTA is forecast to generate $31,853,358,168 in revenue, with the lowest revenue forecast at $30,604,206,868 and the highest revenue forecast at $32,790,221,644.